Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S153878362600680X?dgcid=rss_sd_all
Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S153878362600680X?dgcid=rss_sd_all
“Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study.” Journal of Thrombosis and Haemostasis.
@article{article90001,
title = {Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S153878362600680X?dgcid=rss_sd_all}
}